About: http://data.cimple.eu/news-article/d4e89ed005e786428162bd9addc3e5eec6229675289e81f0008f8a8c

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/d4e89ed005e786428162bd9addc3e5eec6229675289e81f0008f8a8c Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	South Africa in Tuesday stepped up its push to waive intellectual property rights over coronavirus jabs, arguing this could help poorer nations close a "global gap" on vaccine access. Foreign Minister Naledi Pandor reiterated Pretoria's position -- shared with other major players like India and with the World Health Organization (WHO) -- that "none of us are safe until all of us are safe". Securing a waiver agreement "will allow use of intellectual property, the sharing of technologies and technology transfer," Pandor told a meeting of the BRICS group of emerging economies, enabling "the production of vaccine therapeutics and wider distribution". Formed in 2006, BRICS groups Brazil, Russia, India, China and South Africa. South Africa and India are leading a global campaign at the World Trade Organization (WTO) to temporarily waive intellectual property rights for Covid vaccines. Supporters of the move argue it will spur production of low-cost generic vaccines, helping poor countries that are struggling to immunise their people. The US under President Joe Biden has thrown its weight behind the bid alongside China, but other pharmaceutical heavyweights including the EU, Britain and Japan are reluctant. Opponents argue the move will damage intellectual property rights and erode the profit incentive, ultimately affecting pharmaceutical research and development. Pharmaceutical companies also point out that manufacturing a vaccine requires know-how and technical resources which cannot be acquired at the flip of a switch. Pandor, speaking by video link from Pretoria, said "millions of people in wealthier nations have been vaccinated, while billions of people in poorer countries still wait and are still vulnerable to infection, disease and death." Just two percent of global vaccines have been administered in sub-Saharan Africa, according to WHO figures -- a situation that Pandor described as a "global gap of vaccine access." Sixty-three countries have backed the Indian-South African proposal, but unanimity among all 164 WTO member states is needed for agreement. burs-mgu-sn/tgb/ri
schema:headline	SA renews push for vaccine patent waivers
schema:mentions	Intellectual property BRICS Pretoria Foreign minister Pharmaceutical industry Sub-Saharan Africa World Trade Organization World Health Organization South Africa European Union Russia India Coronavirus disease Brazil Joe Biden Vaccine China Severe acute respiratory syndrome coronavirus 2 President of the United States Naledi Pandor dbpedia:Global_Vaccines Technology transfer Renews-Cappahayden Economy of Japan
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-06-01 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	88 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness
http://data.cimple...entionsConspiracy	antivax conspiracy theory

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software